US6700024010 - Common Stock
These companies, thought dead, could pull a Lazarus and rise from the ashes, making them stocks to buy for a comeback.
After pulling back following May's "Sanofi surge," don't rule out the potential for further needle-moving news with Novavax stock.
/CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, announced that it has filed for...
There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well.
We will know a lot more about the vaccine maker's long-term prospects in 12 months.
It's good news for Novavax that the FDA is targeting a particular Covid-19 strain, but Novavax stock is still to pricey to buy now.
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions.
Investors can't miss out on meme stocks to buy on the dip since these represent fundamentally sound ideas with growth acceleration catalysts
InvestorPlace - Stock Market News, Stock Advice & Trading Tips When meme stocks start skyrocketing, it’s difficult to find a good entry ...
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it has filed...
These are the short-squeeze stocks to buy as they represent oversold names with positive impending catalysts.
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it has...
Shares of the vaccine maker are trading up 230% this year.
These are the undervalued penny stocks to buy as they represent emerging companies with potential for robust growth and cash flow upside
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks have the tendency to surprise when it comes to delivering stellar ...